Skip to main content
Fig. 2 | Biomarker Research

Fig. 2

From: Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome

Fig. 2

Relationship between BCL11B and immune infiltrating lymphocytes and CD3 complex genes. A T cell subsets were correlated with BCL11B in the GSE13159 dataset. B Correlation between BCL11B and CD3 complex genes in the GSE13159 (left panel) and GSE114922 (right panel) datasets. C Impact of the CD3D, CD3E, and CD3G expression levels on the OS of MDS patients in the GSE114922 dataset. D Correlation between BCL11B and CD3E or CD3G in bone marrow (BM) samples. E Impact of the combination of BCL11B, CD3E, and CD3G on OS and RMST in MDS patients. Group I: BCL11BhighCD3EhighCD3Ghigh; Group II: BCL11Blow, CD3Elow, or CD3Glow; Group III: BCL11BlowCD3ElowCD3Glow. GDPH, Guangdong Provincial People’s Hospital

Back to article page